Edinburgh Molecular Imaging (EMI), a spin-out of the Scottish capital’s university, has raised £4m ($6.5m) from venture firm Epidarex Capital. The funding will be used to further develop EMI’s imaging technology, used to diagnose and monitor diseases. EMI’s current focus is on lung conditions such as cancer and fibrosis, but will eventually be expanded to…
Epidarex brings in funds to Edinburgh
Feb 10, 2014 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024